Pharma companies must adapt to keep pace with AI developments, say experts
Pharmaceutical Technology
OCTOBER 25, 2024
At the Outsourcing in Clinical Trials Conference, key opinion leaders shared predictions for workflow changes due to AI.
Cloud robotics labs are accelerating drug discovery and development
Pharmaceutical Technology
OCTOBER 28, 2022
Drug discovery and development is an incredibly expensive and time-consuming process, taking between 12 and 18 years, and costing on average between $2 billion and $3 billion. Robots can improve drug discovery and development. Lab-specific industrial co-bots can carry out both complex and repetitive tasks such as liquid handling.
Development 
311
311 Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
IISc researchers find picolinic acid’s broad-spectrum antiviral abilities, scouts for partners in pharma companies
AuroBlog - Aurous Healthcare Clinical Trials blog
AUGUST 3, 2023
The Institute is now looking for partners in pharma companies to pursue further clinical development of the findings. When the compound was tested […]
Pharma Companies 189
189 
CpHI Europe: Pharma companies fail to engage patients early in drug development
Pharmaceutical Technology
OCTOBER 26, 2023
Experts discuss how pharma companies need to consider patient centricity earlier in their development plans.
Pharma Companies 130
130 
Thrust on R&D to develop better medicines & demand for technologies driven by AI transforming patient care
AuroBlog - Aurous Healthcare Clinical Trials blog
APRIL 11, 2023
The pharma companies’ thrust on R&D to develop better medicines and the demand in hospitals for advanced medical technologies driven by artificial intelligence, remote patient monitoring and wearables are transforming patient care.
Medicine 188
188 
Drug development costs predicted to soar as BIOSECURE Act gains momentum
Pharmaceutical Technology
JULY 17, 2024
As US China trade relations are set to be impacted by the BIOSECURE Act, pharma companies exploring CDMOs outside China may need to contend with increased drug development and manufacturing costs.
Development 147
147 
In the News: October Regulatory and Development Updates
Camargo
NOVEMBER 11, 2020
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Still, navigating such patent issues during drug development can be difficult, and Camargo can assist in finding a safe course. Ken Phelps.
Development 242
242 
Takeda ends deal with Finch as bumpy ride continues for microbiome drugs
Bio Pharma Dive
AUGUST 26, 2022
The pharma company terminated a collaboration that could’ve netted the biotech about $350 million. It’s the latest in a string of recent setbacks for microbiome drug developers.
Pharma Companies 242
242 
India needs to develop strategies to mitigate the impact of USAID funding freeze
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 11, 2025
Yet India needs to develop strategies to mitigate the impact of USAID funding freeze for Indian pharma companies. This is even as a large section of companies exporting to the US noted that even if foreign assistance is […]
Development 147
147 
Boehringer extends cancer dealmaking with right to buy biotech partner
Bio Pharma Dive
JUNE 16, 2022
The German pharma company has secured an option to acquire Trutino Biosciences, two years after inking a research collaboration with the San Diego drug developer.
Pharma Companies 219
219 
AstraZeneca to acquire vaccine maker Icosavax for up to $1.1B
Bio Pharma Dive
DECEMBER 12, 2023
The deal signals the pharma company’s continuing interest in vaccine development and hands it a combination shot aimed at two respiratory viruses.
Vaccine 198
198 
HCPs are overwhelmed by promotional content in digital
World of DTC Marketing
JANUARY 11, 2022
As HCPs get more digitally savvy, pharma marketers should understand that engaging physicians through channels and time of their preference with content relevant to the individual customer. Key findings: 77% of HCPs use digital channels primarily for personal learning and development.
Pharma Companies 235
235 
Enhancing mRNA drug development: how to optimise your suppliers and materials
Pharmaceutical Technology
AUGUST 21, 2024
Pharma companies seeking to commercialise in mRNA can gain a competitive edge by partnering with expert suppliers
Pharma Companies 130
130 
Incannex partners with Catalent to manufacture psilocybin
Pharmaceutical Technology
MARCH 6, 2023
Incannex Healthcare has collaborated with New Jersey-based pharma company Catalent for the development and manufacturing of a cGMP-grade psilocybin drug product for clinical trials and potential commercial use. The latest development follows an internal analysis of the preliminary results of the Phase II PsiGAD clinical trial.
Manufacturing 264
264 
AI continues to gain momentum in the biopharmaceutical industry in 2023
Pharmaceutical Technology
JANUARY 16, 2023
In addition to collaborating with AI-technology providers, pharma companies are also engaging in vertical integration. One such emerging technology, artificial intelligence (AI), is expected to play an important role in the pharmaceutical sector in 2023. AI is still at the nascent stages of growth, but its potential is immense.
Big Data 303
303 
The largest pharma company in Europe calls for interoperability
pharmaphorum
APRIL 19, 2022
The first focuses on the patient journey through patient partnerships – spotting areas of challenge for specific patients and developing partnerships with different stakeholders outside Roche to improve upon the patient journey. The post The largest pharma company in Europe calls for interoperability appeared first on.
Pharma Companies 111
111 
Telix revives Olaratumab development with positive preclinical data
Pharmaceutical Technology
APRIL 17, 2023
Telix has announced the successful preclinical development of radiolabelled olaratumab, an antibody licensed by Eli Lilly and Company. Olaratumab will be denoted as TLX300 in Telix’s development pipeline. Telix has demonstrated proof-of-concept (PoC) and will now progress to first-in-human clinical studies.
Development 130
130 
MSD reinforces Amazon partnership for faster AI-led drug discovery and development
Pharmaceutical Technology
NOVEMBER 30, 2023
MSD is one of many pharma companies migrating IT applications to the cloud to transform value chains and harness new technologies.
Pharma Companies 130
130 
Talem and Libera Bio partner for discovery of AI-driven antibodies
Pharmaceutical Technology
MARCH 16, 2023
Under the collaboration, Libera Bio and Talem Therapeutics will together develop new antibodies for use with MPN delivery. These antibodies will be provided to pharma companies for conducting late-stage development and marketing. They deliver the compounds through a cell membrane and to intracellular targets.
Antibody 262
262 
Pfizer hires Citi analyst Andrew Baum to manage portfolio strategy, business development
Fierce Pharma
MAY 6, 2024
“Our next question will come from Andrew Baum with Citi.” | Citi analyst Andrew Baum, after covering Pfizer for more than a decade, will join the Big Pharma company as chief strategy and innovation officer. In the role, he'll oversee the drugmaker's portfolio management and business development activities.
Vox Pop Pharma - companies keen to find alternatives to animal testing - read their views
Outsourcing Pharma
APRIL 19, 2024
revealed its Alternative Methods Advancement Project (AMAP), which it said is a strong initiative aimed at changing drug discovery and development by exploring alternatives to animal testing. Earlier this week, Charles River Laboratories International, Inc.
Streamlining healthcare with AI for drug development
Pharmaceutical Technology
JUNE 15, 2023
AI for drug development is rapidly streamlining R&D processes, speeding up time to market and providing a better experience for patients and providers. Learn more about the role of AI in drug development and how healthcare researchers are using it to shake up the field.
Development 130
130 
How Pharma Companies Can – And Should – Improve Social Determinants of Health
Intouch Solutions
OCTOBER 13, 2023
They can include the conditions in which people are born, live, learn, work, play, worship, and age 1,2 — as well as factors like economic policies and systems, development agendas, social norms, social policies and political systems. Pharmaceutical companies can develop and disperse these materials.
Pharma Companies 105
105 
The current pharma business model is unsustainable
World of DTC Marketing
SEPTEMBER 7, 2022
In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. Biogen’s failure should be a warning to other pharma companies. Now Biogen is a shell of a company selling off assets to survive. It should be a warning to other pharma companies.
Pharma Companies 210
210 
Samsung Biologics and European pharma company enter major manufacturing deal
BioPharma Reporter
NOVEMBER 20, 2024
The global CDMO has entered into several high-value manufacturing deals this year.
Samsung Biologics and European pharma company enter major manufacturing deal
BioPharma Reporter
NOVEMBER 20, 2024
The global CDMO has entered into several high-value manufacturing deals this year.
In the News: February 2021 Regulatory and Development Updates
Camargo
MARCH 9, 2021
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. The FDA revealed that pharma companies are not forthcoming when they publicly disclose the reasons behind a refuse-to-file (RTF) letter from the Agency.
Development 146
146 
Covid vaccine profits and the strain on supply channels
World of DTC Marketing
JANUARY 8, 2021
Pharma companies will make an estimated $40 billion on the global COVID-19 vaccine market this year, which will be split between Johnson & Johnson, AstraZeneca, Novavax, and others. Wall Street has been speculating for a long time on which pharma company is going to make the most from the development of a Covid-19 vaccine.
Vaccine 266
266 
Laurus Labs and IIT Kanpur partner for new gene therapy products
Pharmaceutical Technology
JUNE 19, 2023
Indian pharmaceutical company Laurus Labs has signed a memorandum of agreement (MoA) with the Indian Institute of Technology, Kanpur (IIT Kanpur) to bring new gene therapy products to the market. The company will also establish a GMP facility at IIT Kanpur’s Techno Park facility.
Gene Therapy 246
246 
Opinion: STAT+: Continuous manufacturing can help pharma companies save time, money, and more
STAT News
JANUARY 6, 2023
The pharmaceutical industry has been slow to adopt a business practice that is faster, safer, and more efficient than its current way of operating; that the FDA has been encouraging the industry to implement more widely for years; and that has been used effectively in other industries for decades. I’m talking about continuous manufacturing.
Manufacturing 111
111 
Takeda discontinuing in AAV and rare haematology disease markets
Pharmaceutical Technology
APRIL 13, 2023
The company is aiming to refocus its efforts on its core therapeutic areas and current late-stage programmes such as the oral TYK2 inhibitor TAK-279, which is under development for several autoimmune disorders.
Gene Therapy 243
243 
The biggest transformation in pharma marketing since DTC
World of DTC Marketing
JANUARY 26, 2022
As HCPs get more digitally savvy, pharma marketers should understand that engaging physicians through channels and time of their preference with content relevant to the individual customer. FutureReadyHealthcare listed the following key findings: 77% of HCPs use digital channels primarily for personal learning and development.
Marketing 202
202 
Reaching HCPs online
World of DTC Marketing
APRIL 13, 2021
I reached out to three HCP marketing people at different pharma companies and asked them for their feedback on this survey. 6ix: In-House – Some pharma companies are developing in-house digital solutions to reach HCPs, but it can be costly, and getting physicians to use it can be a challenge.
Doctors 286
286 
Kronos downsizes workforce by 19% to funnel funds into cancer drugs
Pharmaceutical Technology
NOVEMBER 3, 2023
Kronos Bio joins other pharma companies in workforce reductions, cutting 19% of its employees to support clinical development.
Pharma Companies 130
130 
How using AI in clinical trials accelerates drug development
Pharmaceutical Technology
JUNE 15, 2023
Pharma R&D teams are solving this problem by leveraging the power of artificial intelligence (AI) in clinical trials to save time and money. Drug development is already a difficult endeavor, with the vast majority of R&D efforts failing to produce a market-worthy product. Food and Drug Administration approval.
Clinical Trials 130
130 
Tapping into digital therapeutics to improve neurological outcomes
Pharmaceutical Technology
MARCH 17, 2023
At the same time, experts are saying developers in the field need to double down on securing clinical data to allow for its continued maturation. Companies are testing the use of digital platforms along with pharmacological treatments. Securing reimbursement for digital therapeutics also continues to impede its uptake.
Production 278
278 
What can pharma companies do to get promising antimicrobials to the frontlines of drug resistance?
Outsourcing Pharma
MAY 23, 2024
A new report from Access to Medicine Foundation gives the advice to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance.
Pharma is hiring
World of DTC Marketing
AUGUST 13, 2020
IN BRIEF: Pharma companies have been posting jobs on LinkedIn almost every day. While most offices remain closed pharma is preparing for the launch of new products and has to have the infrastructure to ensure a successful launch. Yet, too many pharma companies don’t get social media snapshots of what’s being said.
Branding 223
223 
Governments and pharma relationships and implications for antimicrobial resistance
Pharmaceutical Technology
AUGUST 1, 2022
Since 2020, government agencies have provided funding for expensive late-stage vaccine development and the expansion of manufacturing capacity, as well as other key pharmaceutical activities. The shift from private to public funding enabled more rapid development of Covid-19 drugs and vaccines.
Vaccine 234
234 
Universities and pharma companies need each other to create world-changing medicines
pharmaphorum
DECEMBER 18, 2023
Collaborative partnerships between universities and pharmaceutical companies are crucial for advancing biomedical research and development (R&D) and creating groundbreaking medicines. Explore the benefits and significance of these alliances in this informative piece.
How to choose the right digital agency
World of DTC Marketing
JULY 30, 2021
Pharma companies, for the most part, still rely on outside digital agencies for their online work. Here are some of the things I learned in working with digital agencies at pharma. Another area that a lot of agencies need to develop. 9ine: What is their process for developing branded content online?
Branding 286
286 
Pharma’s platinum handcuffs
World of DTC Marketing
JULY 15, 2022
To address the “retention” problem, pharma companies are paying employees exorbitant salaries. This is NOT what pharma needs. They won’t know exactly why, but they often develop a sense of entitlement. This isn’t good for pharma. They will not work as hard as they usually would.
Pharma Companies 257
257 
Pharma is in acquisition mode but small biotechs hurting for money
World of DTC Marketing
JANUARY 10, 2022
Pharma companies are flush with cash and looking to make deals, but there are still a lot of small biotech companies that don’t have enough money to launch their products entirely. billion, which was much lower than previous studies, which have placed the average cost of drug development as $2.8 million $1228.9
Production 213
213 
ESG Top Trends: Technology trends
Pharmaceutical Technology
JULY 21, 2022
AI also speeds up the drug development process, which could translate into cheaper drugs for patients. While large pharma companies have been slow in this area, Merck and GSK are now using 3D printing for clinical trials and manufacturing. Orthopaedic companies have been using 3D printing for their implants for years.
FDA Approval 245
245 
Let's personalize your content